Physician profile
Fermina M Mazzella
NPI 1275522344
$49,030.27
in general payments reported to CMS, 2019-2025
7 companies · $30K in 2025
The $30K reported for 2025 was more than what 98% of Hematology (Pathology) providers received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.37 · 2021: $19K · 2022: $41.71 · 2023: $57.99 · 2024: $13.61 · 2025: $30K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $30K · Food and Beverage: $71.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $29,760.00 |
| Food and Beverage | $71.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $48,860.00 | 2021-2025 | |
| Siemens Medical Solutions USA, INC. | $71.60 | 2023-2024 | Automated Blood Coagulation Analyzer Cs-2500 |
| Roche Diagnostics Corporation | $39.59 | 2021 | |
| Phadia US INC. | $29.79 | 2022 | |
| Abbott Laboratories | $17.37 | 2019 | |
| Beckman Coulter, INC. | $11.92 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fermina Mazzella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.